CombinatoRx to Merge with Neuromed
CombinatoRx has signed an all-stock merger agreement with Neuromed.
CombinatoRx has signed an all-stock merger agreement with Neuromed.
Just days after the World Health Organization declared a swine flu pandemic, Fierce Biotech reports that two pharmaceutical companies are already racing to complete clinical trials of their H1N1 vaccines.
With flu season approaching, the U.S. federal government has earmarked nearly $1 billion for the development of swine flu vaccines.
Asian countries such as India and Japan have gained notoriety for their talented scientists and innovative contributions to the life sciences. Now, a new contender is emerging as a potential industry leader.
Copyright © 2024 | WordPress Theme by MH Themes